United States· US:0037-0431_374f8c69-4219-47fd-aeda-8edc73da5411
Felbatol
A felbamate product containing felbamate, registered in United States by Viatris Specialty LLC. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Felbamate is registered in 9 of 19 countries.
Countries holding a registration under ATC N03AX10 (felbamate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Felbamate · ATC N03AX10
9 / 19 countries
- Belgiumprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of felbamate costs, country by country.
Normalised to the WHO defined daily dose (2.4 g), the median price runs from $4.40 in United States to $10.58 in Switzerland — a ×2.4 gap.
- United States: $4.40 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Felbamate · price per daily dose (2.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$10.58
- IT Italy$9.01
- US United States$4.40 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FELBAMATE
- Manufacturer
- Viatris Specialty LLC
- Country
- United States (US)
- ATC code
- N03AX10
- ATC class
- Felbamate
- Defined daily dose
- 2.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110037043101100 TABLET in 1 BOTTLE, PLASTIC (0037-0431-01)
- ndc110037-0431-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
267 interactions on record for felbamate.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Felbamate · interactions on record
267 records
- 12 severe
- 221 moderate
- 7 minor
Most severe, free to view
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- EthinylestradiolG03CA01severe
27 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Felbamate in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFelbamate 600mg tabletsSpecial Order
- NetherlandsTaloxa-TABS 600 mg tablettenMedcor Pharmaceuticals B.V.
- SwitzerlandTaloxa 600 mg, TablettenOrganon GmbH
- NorwayTaloxaN.V. Organon - Kloosterstraat
- SwedenTaloxa 600 mg TablettNV Organon
- FranceTALOXA 600 mg, compriméORGANON FRANCE
- BelgiumTaloxa-Susp 600 mg/5 mlOrganon Belgium
- ItalyTALOXA*40 cpr 600 mgORGANON ITALIA Srl
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Taloxa
- Belgium · Taloxa-Susp, Taloxa-Tabs
- Germany · Taloxa, Taloxa Saft
- France · Taloxa
- Hungary · Taloxa
- Italy · Taloxa
- Luxembourg · Taloxa-Susp, Taloxa-Tabs
- Netherlands · Taloxa-Susp, Taloxa-Tabs
- Norway · Taloxa
- Portugal · Taloxa
- Sweden · Taloxa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ece294fa-ac3c-41f3-a7e8-050078f03a9c GET /v1/drugs/ece294fa-ac3c-41f3-a7e8-050078f03a9c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "600",
"substance": "FELBAMATE",
"productndc": "0037-0431",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA020189",
"marketing_category": "NDA"
}See everything about felbamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.